04/08/2015 11:56:35 Free Membership Login

Parexel News (NASDAQ:PRXL)

DateTimeSource
Headline
07/24/20156:27PMDJNSignet Jewelers to Join S&P 500
By Josh Beckerman Signet Jewelers Ltd. (SIG) will join the S&P 500 after the close of trading Tuesday, according to S&P Dow Jones Indices. The jewelry and watch seller is replacing DirecTV (DTV), which was sold to AT&T Inc. (T) for $49 billion on Friday. Inclusion in the index is typically a boon for a stock... More...>>
07/24/20156:10PMPRNUSSignet Jewelers Set to Join the S&P 500; PAREXEL International, Catalent to Join the S&P MidCap 400; Others to Join S&P Small...
Signet Jewelers Set to Join the S&P 500; PAREXEL International, Catalent to Join the S&P MidCap 400; Others to Join S&P SmallCap 600 PR Newswire NEW YORK, July 24, 2015 NEW YORK, July 24, 2015 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P500, S&P MidCap 400 and... More...>>
07/21/20157:00AMPRNUSPAREXEL Launches Next Generation Analytics Capabilities Within Perceptive MyTrials® Platform
PAREXEL Launches Next Generation Analytics Capabilities Within Perceptive MyTrials® Platform Enhancements offer clients cross-study oversight through mobile-enabled reporting and analysis PR Newswire BOSTON, July 21, 2015 BOSTON, July 21, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading... More...>>
07/09/20157:00AMPRNUSPAREXEL Expands Model-Based Drug Development Offering
PAREXEL Expands Model-Based Drug Development Offering PR Newswire BOSTON, July 9, 2015 BOSTON, July 9, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced expanded services and capabilities in model-based drug development (MBDD) through... More...>>
07/07/20159:00AMPRNUSPAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call
PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call PR Newswire BOSTON, July 7, 2015 BOSTON, July 7, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2015 on Wednesday... More...>>
06/23/20154:01PMPRNUSPAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day - Maintains mid-point of prior guidance adjusted diluted earnings per share for Fiscal Year 2015 at $2.74 - Projects high single digit organic revenue growth in Fiscal Year 2016 - Announces Margin Acceleration Program to enhance continuous... More...>>
06/18/20157:00AMPRNUSPAREXEL Launches Next Generation Data-Driven Monitoring Capabilities Within Perceptive MyTrials® Solution
PAREXEL Launches Next Generation Data-Driven Monitoring Capabilities Within Perceptive MyTrials® Solution Enhancements offer clients increased clinical trial efficacy and seamless data-driven monitoring experience PR Newswire BOSTON, June 18, 2015 BOSTON, June 18, 2015 /PRNewswire/ -- PAREXEL International Corporation... More...>>
06/17/20159:00AMPRNUSPAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 24, 2015
PAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 24, 2015 PR Newswire BOSTON, June 17, 2015 BOSTON, June 17, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor... More...>>
06/15/20159:00AMPRNUSPAREXEL Executive Honored With 2015 DIA Global Connector Award
PAREXEL Executive Honored With 2015 DIA Global Connector Award PR Newswire BOSTON, June 15, 2015 BOSTON, June 15, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Alberto Grignolo, PhD, Corporate Vice President, PAREXEL Consulting... More...>>
06/08/20159:00AMPRNUSPAREXEL Experts To Discuss Key Drug Development Insights At DIA 2015 Annual Meeting
PAREXEL Experts To Discuss Key Drug Development Insights At DIA 2015 Annual Meeting PR Newswire BOSTON, June 8, 2015 BOSTON, June 8, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss a broad... More...>>
05/27/20157:00AMPRNUSPAREXEL Enhances ClinPhone® RTSM Service to Simplify and Expedite Randomization and Trial Supply Management for Clinical Stu...
PAREXEL Enhances ClinPhone® RTSM Service to Simplify and Expedite Randomization and Trial Supply Management for Clinical Studies PR Newswire BOSTON, May 27, 2015 BOSTON, May 27, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced... More...>>
05/26/201510:00AMPRNUSPAREXEL International To Present At Goldman Sachs Healthcare Conference
PAREXEL International To Present At Goldman Sachs Healthcare Conference PR Newswire BOSTON, May 26, 2015 BOSTON, May 26, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Goldman Sachs Healthcare Conference in Palos Verdes, CA.  Josef von Rickenbach... More...>>
05/04/201510:00AMPRNUSPAREXEL International to Present at UBS Healthcare Conference
PAREXEL International to Present at UBS Healthcare Conference PR Newswire BOSTON, May 4, 2015 BOSTON, May 4, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Monday, May 18, 2015, in New York City.  Ingo Bank, Senior Vice... More...>>
05/01/20153:05PMARNPAREXEL International Downgraded by Zacks (PRXL)
http://tickerreport.com/banking-finance/491367/parexel-international-downgraded-by-zacks-prxl/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
05/01/20159:21AMARNDeutsche Bank Boosts PAREXEL International Price Target to $68.00 (PRXL)
http://tickerreport.com/banking-finance/490468/deutsche-bank-boosts-parexel-international-price-target-to-68-00-prxl/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/29/20154:02PMPRNUSPAREXEL International Reports Third Quarter Fiscal Year 2015 Results
PAREXEL International Reports Third Quarter Fiscal Year 2015 Results - Gross new business wins of $942.4 million, up 20.6% year-over-year; net book-to-bill ratio of 1.30; backlog at $5.19 billion - 2.0% growth in consolidated service revenue to $502.0 million; 5.1% constant currency revenue growth - SG&A as a percent... More...>>
04/24/201510:37AMARNPAREXEL International Price Target Increased to $62.00 by Analysts at Jefferies Group (PRXL)
http://tickerreport.com/banking-finance/472333/parexel-international-price-target-increased-to-62-00-by-analysts-at-jefferies-group-prxl/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/24/20159:00AMPRNUSPAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials
PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials Award highlights Company's innovative Perceptive MyTrials® Data-Driven Monitoring solution and development team PR Newswire BOSTON, April 24, 2015 BOSTON, April 24, 2015 /PRNewswire/ -- PAREXEL International Corporation... More...>>
04/13/201511:00AMPRNUSPAREXEL Wins IABC 2015 Gold Quill Merit Award for Digital Communications
PAREXEL Wins IABC 2015 Gold Quill Merit Award for Digital Communications International recognition for communication excellence and measurable business results PR Newswire BOSTON, April 13, 2015 BOSTON, April 13, 2015 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization... More...>>
04/08/20157:00AMPRNUSPAREXEL Strengthens Commitment To Global Biopharmaceutical Workforce With New PAREXEL Academy Programs
PAREXEL Strengthens Commitment To Global Biopharmaceutical Workforce With New PAREXEL Academy Programs - Bachelor of Science Degree in Clinical Research offered in Europe - Postgraduate Certificate in Clinical Trial Management offered in North America - Joint Program for Clinical Research and Clinical Trial Management... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq prxl150804 11:56